February 20, 2018 / 4:16 PM / 6 months ago

BRIEF-Teva Announces Exclusive Launch Of Two Strengths Of A Generic Version Of Solodyn® In The United States

Feb 20 (Reuters) - Teva Pharmaceutical Industries Ltd:

* TEVA ANNOUNCES EXCLUSIVE LAUNCH OF TWO STRENGTHS OF A GENERIC VERSION OF SOLODYN® IN THE UNITED STATES

* TEVA - ‍EXCLUSIVE LAUNCH OF 2 STRENGTHS OF GENERIC VERSION OF SOLODYN (MINOCYCLINE HCL) EXTENDED RELEASE TABLETS, 65 AND 115 MG, IN U.S.​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below